Changing slopes: can we be moving toward improved early treatment response prediction in breast cancer?

Nogueira, Luísa; Adubeiro, Nuno; Nunes, Rita G.; Nogueira, Luisa

http://hdl.handle.net/10400.22/32469

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
Editorial_Luísa Nogueira.pdf		272.77 KB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Resumo(s)

Breast cancer is the most common malignant cancer among women worldwide. For locally advanced disease and selected early-stage cases of human epidermal growth factor receptor 2 (HER-2)-positive and triple-negative breast cancers (TNBC), neoadjuvant chemotherapy (NAC) is the standard of care. NAC reduces tumor burden, facilitates axillary surgery de-escalation, increases the feasibility of breast-conserving surgery and aims to achieve a pathological complete response (pCR). Attaining pCR after NAC is associated with improved disease-free and overall survival rates, providing valuable prognostic information.

Palavras-chave

Breast cancer Malignant cancer Human epidermal

URI

http://hdl.handle.net/10400.22/32469

Citação

Nogueira, L., Adubeiro, N., & Nunes, R. G. (2026). Changing slopes: Can we be moving toward improved early treatment response prediction in breast cancer? European Radiology, 36(5), 4273–4275. https://doi.org/10.1007/s00330-025-12204-w

Editora

Springer Nature

DOI

10.1007/s00330-025-12204-w

Coleções

ESS - RAD - Artigos

Licença CC

Sem licença CC

Métricas Alternativas

Ver registo completo